<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="ACETYLSALICYLIC ACID" rxcui="1191">
<ATC code="A01AD05" />
<ATC code="B01AC06" />
<ATC code="N02BA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="ORAL ANTICOAGULANTS " code="B01A-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="TRICYCLIC ANTIDEPRESSANTS" code="N06AA-001" /></DRUG2>
<DESCRIPTION>Increase of the plasma concentrations of the tricyclic antidepressant with risk of convulsions and increase of the undesirable effects

</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="NON STEROIDAL ANTI-INFLAMMATORY DRUGS" code="M01A-002" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="CYPROHEPTADINE" rxcui="3013">
<ATC code="R06AX02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of decrease of the effectiveness of the antidepressant</DESCRIPTION>
<SEVERITY>Take into account </SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS (MAOI)" code="N06AF0" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="REVERSIBLE MAOI-A, INCLUDING LINEZOLIDE AND METHYLENE BLUE" code="NO6AG-001" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="LITHIUM" rxcui="6448">
<ATC code="D11AX04" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="ST JOHNS WORT" rxcui="258326">
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="ORLISTAT" rxcui="37925">
<ATC code="A08AB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of therapeutic failure when there is concomitant treatment with orlistat</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<DRUG name="TRAMADOL " rxcui="10689">
<ATC code="N02AX02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of appearance of convulsions and/or a serotonin syndrome</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>293-SELECTIVE-SEROTONIN-REUPTAKE-INHIBITORS-(SSRIs).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) " code="N06AB" /></DRUG1>
<DRUG2>
<CLASS name="TRIPTANS" code="N02CC-001" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome </DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
